
Opinion|Videos|December 23, 2024
Advancing IgA Nephropathy Care: Emerging Therapies, Unmet Needs, and Economic Considerations
Advertisement
Episodes in this series

Now Playing
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Oral PCSK9 Inhibitor Enlicitide Matches Injectables in Lowering LDL Cholesterol
2
Integrating Sotatercept Into PAH Care: Vallerie McLaughlin, MD
3
Efficacy and Equity With Oral PCSK9s: Ann Marie Navar, MD, PhD
4
Eosinophilia Linked With Immune-Related Adverse Events in NSCLC Treatment
5















































